E-LIB Suche - Ergebnisse für: Rumi, Elisa

1

Germline MPL mutations may be a rare cause of "triple-negat..:

Borsani, Oscar ; Pietra, Daniela ; Casetti, Ilaria Carola...
Experimental Hematology. 129 (2024) - p. 104127 , 2024

Link: https://doi.org/10.1016/..

2

The evolutionary journey from essential thrombocythaemia to..:

Borsani, Oscar ; Boveri, Emanuela ; Riccaboni, Giacomo...
The Lancet Haematology. 11 (2024) 7 - p. e550 , 2024

Link: https://doi.org/10.1016/..

3

Evaluation of the ATM L2307F germline variant in 121 Italia..:

Borsani, Oscar ; Jäger, Roland ; Pietra, Daniela...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

4

Treatment comparison of hydroxyurea versus ruxolitinib in e..:

Grunwald, Michael R. ; Ritchie, Ellen K. ; Rumi, Elisa...
eJHaem. , 2024

Link: https://doi.org/10.1002/..

5

Incidence of blast phase in myelofibrosis according to anem..:

Mora, Barbara ; Maffioli, Margherita ; Rumi, Elisa...
eJHaem. 4 (2023) 3 - p. 679-689 , 2023

Link: https://doi.org/10.1002/..

6

SARS-CoV-2 vaccination and thrombotic risk in myeloprolifer..:

Borsani, Oscar ; Ferretti, Virginia V. ; Casetti, Ilaria C....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) 2 - p. 100122 , 2023

Link: https://doi.org/10.1016/..

7

Ropeginterferon phase 2 randomized study in low-risk polycy..:

Barbui, Tiziano ; Carobbio, Alessandra ; De Stefano, Valerio...
Annals of Hematology. 103 (2023) 2 - p. 437-442 , 2023

Link: https://doi.org/10.1007/..

8

POSTER: MPN-556 Treatment Comparison of Hydroxyurea vs Ruxo..:

Grunwald, Michael R. ; Ritchie, Ellen ; Rumi, Elisa...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S192 , 2023

Link: https://doi.org/10.1016/..

9

MPN-193 Incidence of Blast Phase in Myelofibrosis According..:

Mora, Barbara ; Maffioli, Margherita ; Rumi, Elisa...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S386-S387 , 2023

Link: https://doi.org/10.1016/..

10

The impact of thrombosis on probabilities of death and dise..:

Barbui, Tiziano ; Carobbio, Alessandra ; Thiele, Juergen...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

SH2B3 GERMLINE MUTATION CAUSE A MULTISYSTEM DISORDER WITH P..:

Leardini, Davide ; Cerasi, Sara ; Baccelli, Francesco...
EJC Paediatric Oncology. 2 (2023) - p. 100042 , 2023

Link: https://doi.org/10.1016/..

12

Survival expectation after thrombosis and overt-myelofibros..:

Carobbio, Alessandra ; Vannucchi, Alessandro Maria ; Rumi, Elisa...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

P1046: TREATMENT COMPARISON OF HYDROXYUREA VS RUXOLITINIB I..:

Grunwald, Michael ; Ritchie, Ellen ; Rumi, Elisa...
HemaSphere. 7 (2023) S3 - p. e94647fb , 2023

Link: https://doi.org/10.1097/..

14

Assessment of the efficacy and tolerability of ruxolitinib ..:

Coltro, Giacomo ; Sant'Antonio, Emanuela ; Palumbo, Giuseppe A....
Cancer Medicine. 12 (2023) 7 - p. 8166-8171 , 2023

Link: https://doi.org/10.1002/..

15

POSTER: MPN-193 Incidence of Blast Phase in Myelofibrosis A..:

Mora, Barbara ; Maffioli, Margherita ; Rumi, Elisa...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S190 , 2023

Link: https://doi.org/10.1016/..